Siegfried Holding AG (SGFEF)
SGFEF Stock Price Chart
Explore Siegfried Holding AG interactive price chart. Choose custom timeframes to analyze SGFEF price movements and trends.
SGFEF Company Profile
Discover essential business fundamentals and corporate details for Siegfried Holding AG (SGFEF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
25 Jul 2014
Employees
3.89K
Website
https://www.siegfried.chCEO
Marcel Imwinkelried
Description
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
SGFEF Financial Timeline
Browse a chronological timeline of Siegfried Holding AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 16 Feb 2026
Earnings released on 21 Aug 2025
EPS came in at $1.89 falling short of the estimated $2.02 by -6.44%, while revenue for the quarter reached $782.11M , missing expectations by -0.36%.
Stock split effective on 28 Apr 2025
Shares were split 10 : 1 , changing the number of shares outstanding and the price per share accordingly.
Dividend declared on 22 Apr 2025
A dividend of $4.66 per share was announced, adjusted to $0.47. The dividend was paid on 24 Apr 2025.
Earnings released on 18 Feb 2025
EPS came in at $22.50 surpassing the estimated $2.26 by +895.58%, while revenue for the quarter reached $742.86M , missing expectations by -1.75%.
Earnings released on 22 Aug 2024
EPS came in at $18.50 surpassing the estimated $1.71 by +981.87%, while revenue for the quarter reached $691.86M , beating expectations by +1.09%.
Dividend declared on 3 May 2024
A dividend of $3.98 per share was announced, adjusted to $0.40. The dividend was paid on 7 May 2024.
Earnings released on 18 Apr 2024
EPS came in at $7.72 surpassing the estimated $2.20 by +250.91%, while revenue for the quarter reached $776.52M , missing expectations by -2.30%.
Earnings released on 30 Jun 2023
EPS came in at $14.48 surpassing the estimated $1.52 by +852.63%, while revenue for the quarter reached $676.79M , beating expectations by +3.70%.
Dividend declared on 9 May 2023
A dividend of $3.81 per share was announced, adjusted to $0.38. The dividend was paid on 11 May 2023.
Earnings released on 31 Dec 2022
EPS came in at $23.54 surpassing the estimated $1.81 by +1.20K%, while revenue for the quarter reached $694.99M , missing expectations by -3.64%.
Earnings released on 30 Jun 2022
EPS came in at $15.15 surpassing the estimated $1.00 by +1.42K%, while revenue for the quarter reached $612.49M , beating expectations by +6.64%.
Dividend declared on 30 Jun 2022
A dividend of $3.35 per share was announced, adjusted to $0.34. The dividend was paid on 4 Jul 2022.
Earnings released on 31 Dec 2021
EPS came in at $12.04 surpassing the estimated $1.63 by +638.65%, while revenue for the quarter reached $602.78M , missing expectations by -9.05%.
Dividend declared on 7 Jul 2021
A dividend of $3.24 per share was announced, adjusted to $0.32. The dividend was paid on 9 Jul 2021.
Earnings released on 30 Jun 2021
EPS came in at $11.92 surpassing the estimated $0.86 by +1.28K%, while revenue for the quarter reached $596.70M , beating expectations by +17.76%.
Earnings released on 31 Dec 2020
EPS came in at $8.02 falling short of the estimated $12.03 by -33.33%, while revenue for the quarter reached $477.89M , missing expectations by -6.88%.
SGFEF Stock Performance
Access detailed SGFEF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.